Medical Journals

Differential Induction of Leishmania Donovani Bi-subunit Topoisomerase I-dna Cleavage Complex by Selected Flavones and Camptothecin: Activity of Flavones Against Camptothecin-resistant Topoisomerase I.

Authors:
  • Das Benu Brata
  • Sen Nilkantha
  • Roy Amit
  • Dasgupta Somdeb Bose
  • Ganguly Agneyo
  • Mohanta Bikash Chandra
  • Dinda Biswanath
  • Majumder Hemanta K

From: Department of Molecular Parasitology, Indian Institute of Chemical Biology, 4, Raja S.C Mullick Road, Kolkata 700032, India.

Nucleic acids research

  • Publish Date: 2006
  • ISSN: 1362-4962
  • Volume: 34
  • Issue: 4
  • Pages: 1121-32
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Das Benu Brata, Sen Nilkantha, Roy Amit, et al. Differential Induction of Leishmania Donovani Bi-subunit Topoisomerase I-dna Cleavage Complex by Selected Flavones and Camptothecin: Activity of Flavones Against Camptothecin-resistant Topoisomerase I.. Nucleic Acids Res. 2006;34:1121-32

Abstract

Emergence of the bi-subunit topoisomerase I in the kinetoplastid family (Trypanosoma and Leishmania) has brought a new twist in topoisomerase research related to evolution, functional conservation and preferential sensitivities to the specific inhibitors of type IB topoisomerase family. In the present study, we describe that naturally occurring flavones baicalein, luteolin and quercetin are potent inhibitors of the recombinant Leishmania donovani topoisomerase I. These compounds bind to the free enzyme and also intercalate into the DNA at a very high concentration (300 microM) without binding to the minor grove. Here, we show that inhibition of topoisomerase I by these flavones is due to stabilization of topoisomerase I-DNA cleavage complexes, which subsequently inhibit the religation step. Their ability to stabilize the covalent topoisomerase I-DNA complex in vitro and in living cells is similar to that of the known topoisomerase I inhibitor camptothecin (CPT). However, in contrast to CPT, baicalein and luteolin failed to inhibit the religation step when the drugs were added to pre-formed enzyme substrate binary complex. This differential mechanism to induce the stabilization of cleavable complex with topoisomerase I and DNA by these selected flavones and CPT led us to investigate the effect of baicalein and luteolin on CPT-resistant mutant enzyme LdTOP1Delta39LS lacking 1-39 amino acids of the large subunit [B. B. Das, N. Sen, S. B. Dasgupta, A. Ganguly and H. K. Majumder (2005) J. Biol. Chem. 280, 16335-16344]. Baicalein and luteolin stabilize duplex oligonucleotide cleavage with LdTOP1Delta39LS. This observation was further supported by the stabilization of in vivo cleavable complex by baicalein and luteolin with highly CPT-resistant L.donovani strain. Taken together, our data suggest that the interacting amino acid residues of topoisomerase I may be partially overlapping or different for flavones and CPT. This study illuminates new properties of the flavones and provide additional insights into the ligand binding properties of L.donovani topoisomerase I.

Mesh Headings (Keywords): Animals, Camptothecin, DNA, DNA Topoisomerases, Type I, Eukaryotic, Enzyme Inhibitors, Flavanones, Flavonoids, Leishmania donovani, Luteolin, Mutation, Protein Subunits, Protozoan Proteins, Quercetin


Check for Full Text / PubMed Unique Identifier (PMID): 16488884


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.